Britt Meelby Jensen

From 2019 to. Britt Meelby Jensen is a Danish citizen.

Biotech Of The Week Zealand Pharma Danish Biotech Success Story

1 day agoBritt Meelby Jensen is the new CEO of Ambu Photo via Atos Medical Ambu today said it has hired Board Member Britt Meelby Jensen to replace CEO Juan Jose Gonzalez effective tomorrow.

. Jensen previously was Chief Executive Officer at Zealand Pharma A Chief Executive Officer at Atos Medical AB Vice President General Manager at Dako Denmark ApS and Chief Executive Officer for. Britt Meelby Jensen has served as board member of The Board of Directors of Ambu AS has appointed Britt Meelby Jensen as new Chief Executive Officer CEO. Britt Meelby Jensen is Vice President at Agilent Technologies Inc.

Den verden Danmark vender tilbage til efter Covid-19 er en radikalt. 1 day agoBritt Meelby Jensen born in 1973 has more than 20 years of experience from the life science industry. She holds a MSc in International Marketing and Management from Copenhagen Business School and has earned an MBA from Solvay Business School Université Libre de Bruxelles.

After three years at the front of Swedish medtech company Atos Medical Britt Meelby Jensen has set the date for when she will leave the company a press release announces. At Atos Medical we are also devoted to voice. Member of the Novo Advisory Group Novo Holdings.

From 2019 Britt Meelby Jensen served as CEO of Swedish Atos Medical until she led the sale. Britt Meelby Jensen has served as board member of Ambu since 2019 a position she will step down from when she takes over the position as CEO on 20 May 2022 and replaces Juan Jose Gonzalez who will leave Ambu after three years and support the. På valg i 2024.

Direktør i Ambu er den rette kandidat til at genskabe tilliden til medicoselskabet efter blandt andet syv nedjusteringer på tre år. From 2019 Britt Meelby Jensen served as CEO of Swedish Atos Medical until she led the sale of the company to Coloplast in early 2022. President and CEO Zealand Pharma AS.

Britt has over twenty years of experience from the life science industry pharma diagnostics biotech and medtech. Britt Meelby Jensen born in 1973 has more than 20 years of experience from the life science industry. Britt Meelby Jensen synes godt om dette.

Britt Meelby Jensen has served as board member of Ambu since 2019 a position she will step down from when she takes over the position as CEO on 20 May 2022 and replaces Juan Jose Gonzalez who will leave Ambu after three years and support the new CEO in the transition as needed. Britt Meelby Jensen Work Experience and Education. Det vil hun rette op på Den erfarne topchef Britt Meelby Jensen skal nu vende udviklingen i det pressede medicoselskab Ambu.

Chief Executive Officer Atos Medical. 1 day agoBritt Meelby Jensen has served as board member of Ambu since 2019 a position she will step down from when she takes over the position as CEO on 20 May 2022 and replaces Juan Jose Gonzalez who. Ambus nye topchef Britt Meelby Jensen erkender at syv nedjusteringer på tre år har tæret på tilliden til selskabet.

Britt Meelby Jensen has served as CEO of Atos Medical since 2019 after serving as CEO of Zealand Pharma AS and Dako AS previously. Member of the Board Hempel Foundation Hempel Invest AS. Competencies and special tasks on the Board.

For sin rolle i Atos. View Britt Meelby Jensens professional profile on Relationship Science the database of decision makers. Member of the Board Ambu AS.

On March 1 2022 the former Zealand Pharma CEO steps back from the position in Atos Medical which Coloplast acquired for EUR 22bn in November. Britt Meelby Jensen har senest været administrerende direktør for Swedish Atos Medical der senere blev solgt til til Coloplast. From 2015 to 2019 Britt Meelby Jensen was CEO of Zealand Pharma.

Since Juan Jose Gonzalez joined as CEO in 2019 Ambu has made good. Hun har en del kredit i markedet bla. Genvalgt senest i 2021.

Britt Meelby Jensen has served as board member of Ambu since 2019 a position she will step down from when she takes over the position as CEO on 20 May 2022 and replaces Juan Jose Gonzalez who will leave Ambu after three years and support the new CEO in the transition as needed. Furthermore she has in-depth knowledge and understanding of the Novo Group having held various leadership positions between 2002-2013 at Novo Nordisk AS. Britt Meelby Jensen has been appointed CEO of the Swedish medtech company Atos Medical.

International Marketing Management Copenhagen Business School 2000 MBA Economics Solvay Business. As previously reported Britt Meelby Jensen has left her position as CEO of Zealand Pharma and now it is official that she is the new CEO of Atos Medical. His place at the helm will be taken over by Britt Meelby Jensen who has been a board member of Ambu since 2019 a position she leaves as part of the executive reshuffle.

Today is World Voice Day an annual event dedicated to the celebration of the phenomenon of voice. For example the establishment of a permanent Life Science office referring to the Danish Minister for Industry Business and Financial Affairs is a step in the right direction says Meelby Jensen. 8 hours agoBritt Meelby Jensen der torsdag blev udpeget til ny adm.

Since Juan Jose Gonzalez joined as CEO in 2019 Ambu has made. 1 day agoEffective tomorrow May 20 Juan Jose Gonzalez will no longer be the chief executive of Danish medtech firm Ambu the firm has announced in a press release. Sådan lyder vurderingen fra flere analytikere ifølge Finans.

Fra 2015-2019 var Britt Meelby Jensen administrerende direktør for det børsnoterede biotekselskab Zealand Pharma og hun har tidligere også stået i spidsen for Dako og har haft ledende stillinger i Novo Nordisk. The medtech company is based in Malmö Sweden and is focused on laryngectomy care. The Board of Directors of Ambu AS has appointed Britt Meelby Jensen as new Chief Executive Officer CEO.

After this interview in December 2018 Britt Meelby Jensen left Zealand Pharma to become the new CEO of Atos Medical. Britt Meelby Jensen is on the board of Novo Holdings An and 6 other companies. Press Releases One News Page.

Kompetencer og særlige opgaver i bestyrelsen. Britt Meelby Jensen var den oplagte kandidat. CEO and General Manager Dako.

The Board of Directors of Ambu AS has appointed Britt Meelby Jensen as new Chief Executive Officer. International Marketing Management Copenhagen Business School 2000.

Troester Named New Director Of Center For Environmental Health And Susceptibility Unc Gillings School Of Global Public Health